1985
DOI: 10.1016/0748-5514(85)90014-5
|View full text |Cite
|
Sign up to set email alerts
|

Post resuscitation iron delocalization and malondialdehyde production in the brain following prolonged cardiac arrest

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

3
14
0

Year Published

1987
1987
2010
2010

Publication Types

Select...
5
4

Relationship

0
9

Authors

Journals

citations
Cited by 80 publications
(17 citation statements)
references
References 50 publications
3
14
0
Order By: Relevance
“…As shown in Fig. 5, tissue levels oflow molecular weight iron chelates are increased in ischemic reperfused lung in a similar magnitude as reported in ischemic reperfused brain (17) and heart (49). Furthermore, the increase iron is prevented by 8-methoxypsoralen, piperonyl butoxide, or cimetidine.…”
Section: Discussionsupporting
confidence: 66%
See 1 more Smart Citation
“…As shown in Fig. 5, tissue levels oflow molecular weight iron chelates are increased in ischemic reperfused lung in a similar magnitude as reported in ischemic reperfused brain (17) and heart (49). Furthermore, the increase iron is prevented by 8-methoxypsoralen, piperonyl butoxide, or cimetidine.…”
Section: Discussionsupporting
confidence: 66%
“…In reperfusion injury iron appears to promote tissue damage by catalyzing hydroxyl radical ('OH) generation via the Fenton reaction and by propagating lipid peroxidation. Recently, the iron chelator deferoxamine has been shown to prevent reperfusion injury in the heart (14), intestine (15), skin (16), brain (17), and lung (18). While much activity has been directed toward defining the source of O°and H202 in reperfusion injury, little attention has been paid to locating the intracellular sources of iron, although ferritin has been implicated (19,20).…”
Section: Introductionmentioning
confidence: 99%
“…Iron chelators such as deferoxamine are logical candidates to probe the role of these reactions in ischemic brain. Deferoxamine-treatment has been associated with reduced lipid peroxidation, improved post-ischemic vasoreactivity, cerebral perfusion and ATP recovery (Hurn et al, 1995;Liachenko et al, 2003;Nayini et al, 1985;Nelson et al, 1992). Unfortunately, histological/behavioral outcome studies have failed to find consistent benefit from this strategy (Fleischer et al, 1987;Kumar et al, 1988), possibly due to its short-half-life.…”
Section: Metal Chelatorsmentioning
confidence: 99%
“…The extent of this iron delocalization correlates well with the increase in oxidative stress (measured as the peroxidation of tissue lipids) encountered upon reperfusion and with the subsequent physiological dysfunction of the organs upon transplantation [6]. Delocalization of iron as a result of ischaemia/reperfusion has also been shown to occur in brain tissue [7]. The central role of iron in the formation of highly toxic oxygen-derived free radicals and the evidence for delocalization of this metal ion to potentially more active forms during ischaemia/reperfusion provides a basis for the use of iron chelators for alleviating the damage caused by prolonged ischaemia.…”
Section: Introductionmentioning
confidence: 99%